Revolutionizing therapeutic drug monitoring with the use of interstitial fluid and microneedles technology

Pharmaceutics

Volumn 9, Issue 4, 2017, Pages

  Kiang, Tony K L ^a   Ranamukhaarachchi, Sahan A ^b   Ensom, Mary H H ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Clinical pharmacokinetics; Interstitial fluid; Microneedles; Therapeutic drug monitoring

Indexed keywords

ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT;

BIOTECHNOLOGY; CLINICAL RESEARCH; COMMERCIAL PHENOMENA; DRUG CLASSIFICATION; DRUG MONITORING; FEASIBILITY STUDY; HUMAN; INTERSTITIAL FLUID; MINIMALLY INVASIVE PROCEDURE; NONHUMAN; PAIN; QUALITATIVE RESEARCH; REVIEW; SKIN; VALIDATION STUDY;

EID: 85032023681     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics9040043     Document Type: Review

References (89)

1. Kiang, T.K.; Hafeli, U.O.; Ensom, M.H. A Comprehensive Review on the Pharmacokinetics of Antibiotics in Interstitial Fluid Spaces in Humans: Implications on Dosing and Clinical Pharmacokinetic Monitoring. Clin. Pharmacokinet. 2014, 53, 695-730.
2. Koka, S.; Beebe, T.J.; Merry, S.P.; DeJesus, R.S.; Berlanga, L.D.; Weaver, A.L.; Montori, V.M.; Wong, D.T. The Preferences of Adult Outpatients in Medical or Dental Care Settings for Giving Saliva, Urine or Blood for Clinical Testing. J. Am. Dent. Assoc. 2008, 139, 735-740.
3. Pichini, S.; Altieri, I.; Zuccaro, P.; Pacifici, R. Drug Monitoring in Nonconventional Biological Fluids and Matrices. Clin. Pharmacokinet. 1996, 30, 211-228.
4. Kiang, T.K.; Schmitt, V.; Ensom, M.H.; Chua, B.; Hafeli, U.O. Therapeutic Drug Monitoring in Interstitial Fluid: A Feasibility Study using a Comprehensive Panel of Drugs. J. Pharm. Sci. 2012, 101, 4642-4652.
5. Hafeli, U.O.; Ensom, M.H.; Kiang, T.K.; Stoeber, B.; Chua, B.A.; Pudek, M.; Schmitt, V. Comparison of Vancomycin Concentrations in Blood and Interstitial Fluid: A Possible Model for Less Invasive Therapeutic Drug Monitoring. Clin. Chem. Lab. Med. 2011, 49, 2123-2125.
6. Ranamukhaarachchi, S.A.; Padeste, C.; Dubner, M.; Hafeli, U.O.; Stoeber, B.; Cadarso, V.J. Integrated Hollow Microneedle-Optofluidic Biosensor for Therapeutic Drug Monitoring in Sub-Nanoliter Volumes. Sci. Rep. 2016, 6, 29075.
7. Ensom, M.H.; Davis, G.A.; Cropp, C.D.; Ensom, R.J. Clinical Pharmacokinetics in the 21st Century. Does the Evidence Support Definitive Outcomes? Clin. Pharmacokinet. 1998, 34, 265-279.
8. DiPiro, J.; Blouin, R.; Pruemer, J.; Spruill, W. Concepts in Clinical Pharmacokinetics: A Self-Instructional Course, 2nd ed.; American Society of Health-System Pharmacists Inc.: Bethesda, MD, USA, 1996; p. 200.
9. Kiang, T.K.; Ensom, M.H. Therapeutic Drug Monitoring of Mycophenolate in Adult Solid Organ Transplant Patients: An Update. Expert Opin. Drug Metab. Toxicol. 2016, 12, 545-553.
10. Kiang, T.K.; Ensom, M.H. A Comprehensive Review on the Predictive Performance of the Sheiner-Tozer and Derivative Equations for the Correction of Phenytoin Concentrations. Ann. Pharmacother. 2016, 50, 311-325.
11. Cheng, W.; Kiang, T.K.; Bring, P.; Ensom, M.H. Predictive Performance of the Winter-Tozer and Derivative Equations for Estimating Free Phenytoin Concentration. Can. J. Hosp. Pharm. 2016, 69, 269-279.
12. Kiang, T.K.; Sherwin, C.M.; Spigarelli, M.G.; Ensom, M.H. Fundamentals of Population Pharmacokinetic Modelling: Modelling and Software. Clin. Pharmacokinet. 2012, 51, 515-525.
13. Sherwin, C.M.; Kiang, T.K.; Spigarelli, M.G.; Ensom, M.H. Fundamentals of Population Pharmacokinetic Modelling: Validation Methods. Clin. Pharmacokinet. 2012, 51, 573-590.
14. Bring, P.; Ensom, M.H. Does Oxcarbazepine Warrant Therapeutic Drug Monitoring? A Critical Review. Clin. Pharmacokinet. 2008, 47, 767-778.
15. Tan, J.; Paquette, V.; Levine, M.; Ensom, M.H. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy. Clin. Pharmacokinet. 2017.
16. Kuo, I.F.; Ensom, M.H. Role of Therapeutic Drug Monitoring of Voriconazole in the Treatment of Invasive Fungal Infections. Can. J. Hosp. Pharm. 2009, 62, 469-482.
17. Ng, K.; Mabasa, V.H.; Chow, I.; Ensom, M.H. Systematic Review of Efficacy, Pharmacokinetics, and Administration of Intraventricular Vancomycin in Adults. Neurocrit. Care 2014, 20, 158-171.
18. Stenton, S.B.; Partovi, N.; Ensom, M.H. Sirolimus: The Evidence for Clinical Pharmacokinetic Monitoring. Clin. Pharmacokinet. 2005, 44, 769-786.
19. Ng, J.C.; Leung, M.; Wright, A.J.; Ensom, M.H. Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature. Clin. Pharmacokinet. 2017, 56, 1015-1031.
20. Kendrick, J.G.; Carr, R.R.; Ensom, M.H. Pharmacokinetics and Drug Dosing in Obese Children. J. Pediatr. Pharmacol. Ther. 2010, 15, 94-109.
21. Strong, D.K.; Lai, A.; Primmett, D.; White, C.T.; Lirenman, D.S.; Carter, J.E.; Hurley, R.M.; Virji, M.; Ensom, M.H. Limited Sampling Strategy for Cyclosporine (Neoral) Area under the Curve Monitoring in Pediatric Kidney Transplant Recipients. Pediatr. Transplant. 2005, 9, 566-573.
22. Teng, J.F.; Mabasa, V.H.; Ensom, M.H. The Role of Therapeutic Drug Monitoring of Imatinib in Patients with Chronic Myeloid Leukemia and Metastatic or Unresectable Gastrointestinal Stromal Tumors. Ther. Drug Monit. 2012, 34, 85-97.
23. Schwenger, E.; Dumontet, J.; Ensom, M.H. Does Olanzapine Warrant Clinical Pharmacokinetic Monitoring in Schizophrenia? Clin. Pharmacokinet. 2011, 50, 415-428.
24. Seto, K.; Dumontet, J.; Ensom, M.H. Risperidone in Schizophrenia: Is there a Role for Therapeutic Drug Monitoring? Ther. Drug Monit. 2011, 33, 275-283.
25. Raju, K.S.; Taneja, I.; Singh, S.P.; Wahajuddin. Utility of Noninvasive Biomatrices in Pharmacokinetic Studies. Biomed. Chromatogr. 2013, 27, 1354-1366.
26. Haeckel, R.; Hanecke, P. The Application of Saliva, Sweat and Tear Fluid for Diagnostic Purposes. Ann. Biol. Clin. 1993, 51, 903-910.
27. Aps, J.K.; Martens, L.C. Review: The Physiology of Saliva and Transfer of Drugs into Saliva. Forensic Sci. Int. 2005, 150, 119-131.
28. Nunes, L.A.; Mussavira, S.; Bindhu, O.S. Clinical and Diagnostic Utility of Saliva as a Non-Invasive Diagnostic Fluid: A Systematic Review. Biochem. Med. 2015, 25, 177-192.
29. Mullangi, R.; Agrawal, S.; Srinivas, N.R. Measurement of Xenobiotics in Saliva: Is Saliva an Attractive Alternative Matrix? Case Studies and Analytical Perspectives. Biomed. Chromatogr. 2009, 23, 3-25.
30. Anizan, S.; Huestis, M.A. The Potential Role of Oral Fluid in Antidoping Testing. Clin. Chem. 2014, 60, 307-322.
31. Haeckel, R. Factors Influencing the saliva/plasma Ratio of Drugs. Ann. N. Y. Acad. Sci. 1993, 694, 128-142.
32. Levy, G.; Ellis, E.F.; Koysooko, R. Indirect Plasma-Theophylline Monitoring in Asthmatic Children by Determination of Theophylline Concentration in Saliva. Pediatrics 1974, 53, 873-876.
33. Jusko, W.J.; Gerbracht, L.; Golden, L.H.; Koup, J.R. Digoxin Concentrations in Serum and Saliva. Res. Commun. Chem. Pathol. Pharmacol. 1975, 10, 189-192.
34. Neu, C.; DiMascio, A.; Williams, D. Saliva Lithium Levels: Clinical Applications. Am. J. Psychiatry 1975, 132, 66-68.
35. McAuliffe, J.J.; Sherwin, A.L.; Leppik, I.E.; Fayle, S.A.; Pippenger, C.E. Salivary Levels of Anticonvulsants: A Practical Approach to Drug Monitoring. Neurology 1977, 27, 409-413.
36. Kiang, T.K.; Ensom, M.H. A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans. Clin. Pharmacokinet. 2016, 55, 313-358.
37. Patsalos, P.N.; Berry, D.J. Therapeutic Drug Monitoring of Antiepileptic Drugs by use of Saliva. Ther. Drug Monit. 2013, 35, 4-29.
38. Ter Heine, R.; Beijnen, J.H.; Huitema, A.D. Bioanalytical Issues in Patient-Friendly Sampling Methods for Therapeutic Drug Monitoring: Focus on Antiretroviral Drugs. Bioanalysis 2009, 1, 1329-1338.
39. Pichini, S.; Papaseit, E.; Joya, X.; Vall, O.; Farre, M.; Garcia-Algar, O.; de laTorre, R. Pharmacokinetics and Therapeutic Drug Monitoring of Psychotropic Drugs in Pediatrics. Ther. Drug Monit. 2009, 31, 283-318.
40. Venkatesh, B.; Morgan, T.J.; Cohen, J. Interstitium: The Next Diagnostic and Therapeutic Platform in Critical Illness. Crit. Care Med. 2010, 38, S630-S636.
41. Wiig, H.; Swartz, M.A. Interstitial Fluid and Lymph Formation and Transport: Physiological Regulation and Roles in Inflammation and Cancer. Physiol. Rev. 2012, 92, 1005-1060.
42. Poulin, P. Drug Distribution to Human Tissues: Prediction and Examination of the Basic Assumption in in Vivo Pharmacokinetics-Pharmacodynamics (PK/PD) Research. J. Pharm. Sci. 2015, 104, 2110-2118.
43. Poulin, P. A Paradigm Shift in Pharmacokinetic-Pharmacodynamic (PKPD) Modeling: Rule of Thumb for Estimating Free Drug Level in Tissue Compared with Plasma to Guide Drug Design. J. Pharm. Sci. 2015, 104, 2359-2368.
44. Poulin, P.; Haddad, S. Advancing Prediction of Tissue Distribution and Volume of Distribution of Highly Lipophilic Compounds from a Simplified Tissue-Composition-Based Model as a Mechanistic Animal Alternative Method. J. Pharm. Sci. 2012, 101, 2250-2261.
45. Poulin, P.; Schoenlein, K.; Theil, F.P. Prediction of Adipose Tissue: Plasma Partition Coefficients for Structurally Unrelated Drugs. J. Pharm. Sci. 2001, 90, 436-447.
46. Konings, I.R.; Sleijfer, S.; Mathijssen, R.H.; de Bruijn, P.; Ghobadi Moghaddam-Helmantel, I.M.; van Dam, L.M.; Wiemer, E.A.; Verweij, J.; Loos, W.J. Increasing Tumoral 5-Fluorouracil Concentrations during a 5-Day Continuous Infusion: A Microdialysis Study. Cancer Chemother. Pharmacol. 2011, 67, 1055-1062.
47. Konings, I.R.; Engels, F.K.; Sleijfer, S.; Verweij, J.; Wiemer, E.A.; Loos, W.J. Application of Prolonged Microdialysis Sampling in Carboplatin-Treated Cancer Patients. Cancer Chemother. Pharmacol. 2009, 64, 509-516.
48. Muller, M.; Mader, R.M.; Steiner, B.; Steger, G.G.; Jansen, B.; Gnant, M.; Helbich, T.; Jakesz, R.; Eichler, H.G.; Blochl-Daum, B. 5-Fluorouracil Kinetics in the Interstitial Tumor Space: Clinical Response in Breast Cancer Patients. Cancer Res. 1997, 57, 2598-2601.
49. Muller, M.; Brunner, M.; Schmid, R.; Mader, R.M.; Bockenheimer, J.; Steger, G.G.; Steiner, B.; Eichler, H.G.; Blochl-Daum, B. Interstitial Methotrexate Kinetics in Primary Breast Cancer Lesions. Cancer Res. 1998, 58, 2982-2985.
50. Blochl-Daum, B.; Muller, M.; Meisinger, V.; Eichler, H.G.; Fassolt, A.; Pehamberger, H. Measurement of Extracellular Fluid Carboplatin Kinetics in Melanoma Metastases with Microdialysis. Br. J. Cancer 1996, 73, 920-924.
51. Thompson, J.F.; Siebert, G.A.; Anissimov, Y.G.; Smithers, B.M.; Doubrovsky, A.; Anderson, C.D.; Roberts, M.S. Microdialysis and Response during Regional Chemotherapy by Isolated Limb Infusion of Melphalan for Limb Malignancies. Br. J. Cancer 2001, 85, 157-165.
52. Quist, S.R.; Quist, J.; Birkenmaier, J.; Stauch, T.; Gollnick, H.P. Pharmacokinetic Profile of Methotrexate in Psoriatic Skin Via the Oral Or Subcutaneous Route using Dermal Microdialysis Showing Higher Methotrexate Bioavailability in Psoriasis Plaques than in Non-Lesional Skin. J. Eur. Acad. Dermatol. Venereol. 2016, 30, 1537-1543.
53. Zhou, Q.; Gallo, J.M. In Vivo Microdialysis for PK and PD Studies of Anticancer Drugs. AAPS J. 2005, 7, E659-E667.
54. Chu, J.; Gallo, J.M. Application of Microdialysis to Characterize Drug Disposition in Tumors. Adv. Drug Deliv. Rev. 2000, 45, 243-253.
55. Roberts, J.A.; Udy, A.A.; Jarrett, P.; Wallis, S.C.; Hope, W.W.; Sharma, R.; Kirkpatrick, C.M.; Kruger, P.S.; Roberts, M.S.; Lipman, J. Plasma and Target-Site Subcutaneous Tissue Population Pharmacokinetics and Dosing Simulations of Cefazolin in Post-Trauma Critically Ill Patients. J. Antimicrob. Chemother. 2015, 70, 1495-1502.
56. Tegeder, I.; Schmidtko, A.; Brautigam, L.; Kirschbaum, A.; Geisslinger, G.; Lotsch, J. Tissue Distribution of Imipenem in Critically Ill Patients. Clin. Pharmacol. Ther. 2002, 71, 325-333.
57. Dahyot, C.; Marchand, S.; Bodin, M.; Debeane, B.; Mimoz, O.; Couet, W. Application of Basic Pharmacokinetic Concepts to Analysis of Microdialysis Data: Illustration with Imipenem Muscle Distribution. Clin. Pharmacokinet. 2008, 47, 181-189.
58. Varghese, J.M.; Jarrett, P.; Wallis, S.C.; Boots, R.J.; Kirkpatrick, C.M.; Lipman, J.; Roberts, J.A. Are Interstitial Fluid Concentrations of Meropenem Equivalent to Plasma Concentrations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy? J. Antimicrob. Chemother. 2015, 70, 528-533.
59. Housman, S.T.; Bhalodi, A.A.; Shepard, A.; Nugent, J.; Nicolau, D.P. Vancomycin Tissue Pharmacokinetics in Patients with Lower-Limb Infections Via in Vivo Microdialysis. J. Am. Podiatr. Med. Assoc. 2015, 105, 381-388.
60. Hamada, Y.; Kuti, J.L.; Nicolau, D.P. Vancomycin Serum Concentrations do Not Adequately Predict Tissue Exposure in Diabetic Patients with Mild to Moderate Limb Infections. J. Antimicrob. Chemother. 2015, 70, 2064-2067.
61. Skhirtladze, K.; Hutschala, D.; Fleck, T.; Thalhammer, F.; Ehrlich, M.; Vukovich, T.; Muller, M.; Tschernko, E.M. Impaired Target Site Penetration of Vancomycin in Diabetic Patients Following Cardiac Surgery. Antimicrob. Agents Chemother. 2006, 50, 1372-1375.
62. Ito, Y.; Inagaki, Y.; Kobuchi, S.; Takada, K.; Sakaeda, T. Therapeutic Drug Monitoring of Vancomycin in Dermal Interstitial Fluid using Dissolving Microneedles. Int. J. Med. Sci. 2016, 13, 271-276.
63. Linder, C.; Andersson, M.; Wide, K.; Beck, O.; Pohanka, A. A LC-MS/MS Method for Therapeutic Drug Monitoring of Carbamazepine, Lamotrigine and Valproic Acid in DBS. Bioanalysis 2015, 7, 2031-2039.
64. Stahle, L.; Alm, C.; Ekquist, B.; Lundquist, B.; Tomson, T. Monitoring Free Extracellular Valproic Acid by Microdialysis in Epileptic Patients. Ther. Drug Monit. 1996, 18, 14-18.
65. Lindberger, M.; Tomson, T.; Stahle, L. Validation of Microdialysis Sampling for Subcutaneous Extracellular Valproic Acid in Humans. Ther. Drug Monit. 1998, 20, 358-362.
66. Lindberger, M.; Tomson, T.; Wallstedt, L.; Stahle, L. Distribution of Valproate to Subdural Cerebrospinal Fluid, Subcutaneous Extracellular Fluid, and Plasma in Humans: A Microdialysis Study. Epilepsia 2001, 42, 256-261.
67. Lindberger, M.; Tomson, T.; Stahle, L. Unbound Valproate Fraction in Plasma and Subcutaneous Microdialysate in Steady State and After a Single Dose in Humans. Ther. Drug Monit. 2003, 25, 378-383.
68. Lindberger, M.; Tomson, T.; Lars, S. Microdialysis Sampling of Carbamazepine, Phenytoin and Phenobarbital in Subcutaneous Extracellular Fluid and Subdural Cerebrospinal Fluid in Humans: An In Vitro and In Vivo Study of Adsorption to the Sampling Device. Pharmacol. Toxicol. 2002, 91, 158-165.
69. Lindberger, M.; Tomson, T.; Ohman, I.; Wallstedt, L.; Stahle, L. Estimation of Topiramate in Subdural Cerebrospinal Fluid, Subcutaneous Extracellular Fluid, and Plasma: A Single Case Microdialysis Study. Epilepsia 1999, 40, 800-802.
70. Boschmann, M.; Nussberger, J.; Engeli, S.; Danser, A.H.; Yeh, C.M.; Prescott, M.F.; Dahlke, M.; Jordan, J. Aliskiren Penetrates Adipose and Skeletal Muscle Tissue and Reduces Renin-Angiotensin System Activity in Obese Hypertensive Patients. J. Hypertens. 2012, 30, 561-566.
71. Stahle, L.; Arner, P.; Ungerstedt, U. Drug Distribution Studies with Microdialysis. III: Extracellular Concentration of Caffeine in Adipose Tissue in Man. Life Sci. 1991, 49, 1853-1858.
72. Stetina, P.M.; Madai, B.; Kulemann, V.; Kirch, W.; Joukhadar, C. Pharmacokinetics of Scopolamine in Serum and Subcutaneous Adipose Tissue in Healthy Volunteers. Int. J. Clin. Pharmacol. Ther. 2005, 43, 134-139.
73. Groenendaal, W.; von Basum, G.; Schmidt, K.A.; Hilbers, P.A.; van Riel, N.A. Quantifying the Composition of Human Skin for Glucose Sensor Development. J. Diabetes Sci. Technol. 2010, 4, 1032-1040.
74. Ranamukhaarachchi, S. Skin Mechanics, Intradermal Delivery and Biosensing with Hollow Metallic Microneedles. Ph.D. Thesis, University of British Columbia, Vancouver, BC, Canada, December 2016.
75. Wang, P.M.; Cornwell, M.; Prausnitz, M.R. Minimally Invasive Extraction of Dermal Interstitial Fluid for Glucose Monitoring using Microneedles. Diabetes Technol. Ther. 2005, 7, 131-141.
76. Sakaguchi, K.; Hirota, Y.; Hashimoto, N.; Ogawa, W.; Sato, T.; Okada, S.; Hagino, K.; Asakura, Y.; Kikkawa, Y.; Kojima, J.; et al. A Minimally Invasive System for Glucose Area Under the Curve Measurement using Interstitial Fluid Extraction Technology: Evaluation of the Accuracy and Usefulness with Oral Glucose Tolerance Tests in Subjects with and without Diabetes. Diabetes Technol. Ther. 2012, 14, 485-491.
77. Donnelly, R.F.; Mooney, K.; Caffarel-Salvador, E.; Torrisi, B.M.; Eltayib, E.; McElnay, J.C. Microneedle-Mediated Minimally Invasive Patient Monitoring. Ther. Drug Monit. 2014, 36, 10-17.
78. Caffarel-Salvador, E.; Brady, A.J.; Eltayib, E.; Meng, T.; Alonso-Vicente, A.; Gonzalez-Vazquez, P.; Torrisi, B.M.; Vicente-Perez, E.M.; Mooney, K.; Jones, D.S.; et al. Hydrogel-Forming Microneedle Arrays Allow Detection of Drugs and Glucose in Vivo: Potential for use in Diagnosis and Therapeutic Drug Monitoring. PLoS ONE 2015, 10, e0145644.
79. Romanyuk, A.V.; Zvezdin, V.N.; Samant, P.; Grenader, M.I.; Zemlyanova, M.; Prausnitz, M.R. Collection of Analytes from Microneedle Patches. Anal. Chem. 2014, 86, 10520-10523.
80. Mukerjee, E.V.; Collins, S.D.; Isseroff, R.R.; Smith, R.L. Microneedle Array for Transdermal Biological Fluid Extraction and in Situ Analysis. Sens. Actuators A Phys. 2004, 114, 267-275.
81. Strambini, L.M.; Longo, A.; Scarano, S.; Prescimone, T.; Palchetti, I.; Minunni, M.; Giannessi, D.; Barillaro, G. Self-Powered Microneedle-Based Biosensors for Pain-Free High-Accuracy Measurement of Glycaemia in Interstitial Fluid. Biosens. Bioelectron. 2015, 66, 162-168.
82. Jina, A.; Tierney, M.J.; Tamada, J.A.; McGill, S.; Desai, S.; Chua, B.; Chang, A.; Christiansen, M. Design, Development, and Evaluation of a Novel Microneedle Array-Based Continuous Glucose Monitor. J. Diabetes Sci. Technol. 2014, 8, 483-487.
83. Chang, H.; Zheng, M.; Yu, X.; Than, A.; Seeni, R.Z.; Kang, R.; Tian, J.; Khanh, D.P.; Liu, L.; Chen, P.; et al. A Swellable Microneedle Patch to Rapidly Extract Skin Interstitial Fluid for Timely Metabolic Analysis. Adv. Mater. 2017, 37.
84. Zimmermann, S.; Fienbork, D.; Flounders, A.W.; Liepmann, D. In-Device Enzyme Immobilization: Wafer-Level Fabrication of an Integrated Glucose Sensor. Sens. Actuators B Chem. 2004, 99, 163-173.
85. Chua, B.; Desai, S.P.; Tierney, M.J.; Tamada, J.A.; Jina, A.N. Effect of Microneedles Shape on Skin Penetration and Minimally Invasive Continuous Glucose Monitoring In Vivo. Sens. Actuators A Phys. 2013, 203, 373-381.
86. Heinemann, L.; Glucose Monitoring Study Group. Continuous Glucose Monitoring by Means of the Microdialysis Technique: Underlying Fundamental Aspects. Diabetes Technol. Ther. 2003, 5, 545-561.
87. Tiessena, R.G.; Kapteinab, W.A.; Venemaa, K.; Korf, J. Slow Ultrafiltration for Continuous In Vivo Sampling: Application for Glucose and Lactate in Man. Anal. Chim. Acta 1999, 379, 327-335.
88. Tamada, J.A.; Bohannon, N.J.; Potts, R.O. Measurement of Glucose in Diabetic Subjects using Noninvasive Transdermal Extraction. Nat. Med. 1995, 1, 1198-1201.
89. Kost, J.; Mitragotri, S.; Gabbay, R.A.; Pishko, M.; Langer, R. Transdermal Monitoring of Glucose and Other Analytes using Ultrasound. Nat. Med. 2000, 6, 347-350.